Spots Global Cancer Trial Database for peripheral blood stem cells
Every month we try and update this database with for peripheral blood stem cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | NCT00005785 | Hematologic Neo... HIV Infection | GCSF Mobilized ... | - | National Institutes of Health Clinical Center (CC) | |
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow | NCT00003838 | Myeloproliferat... Acute Myelogeno... Chronic Myeloge... Myelodysplastic... Acute Lymphobla... | T-cell replete ... Methotrexate Cyclosporine G-CSF | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma | NCT00002221 | Lymphoma, Non-H... HIV Infections | Peripheral bloo... | 18 Years - 60 Years | NIH AIDS Clinical Trials Information Service | |
Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. | NCT01728389 | Leukemia Lymphoma | Intrabone trans... | 18 Years - 55 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | NCT06001385 | Acute Lymphobla... Acute Myeloid L... Acute Leukemia Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Lymphoma Chronic Myelomo... Pro-Lymphocytic... Myelofibrosis | Busulfan Fludarabine PBSC Hematopoie... Post-Transplant... Mesna Tacrolimus Mycophenolate M... Patient Reporte... Melphalan Total-body irra... Cyclophosphamid... | 18 Years - | Center for International Blood and Marrow Transplant Research | |
Stem Cell Transplantation for Metastatic Solid Tumors | NCT00001880 | Neoplasm Metast... | methotrexate Cyclosporin | 10 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow | NCT00003838 | Myeloproliferat... Acute Myelogeno... Chronic Myeloge... Myelodysplastic... Acute Lymphobla... | T-cell replete ... Methotrexate Cyclosporine G-CSF | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies | NCT00001748 | Graft vs Host D... Hematologic Neo... Lymphoma Myelodysplastic... Myeloid Leukemi... | Peripheral bloo... | - | National Institutes of Health Clinical Center (CC) | |
Haploidentical Donor vs mMUD in Hematological Malignancies | NCT03275636 | AML ALL MDS | Peripheral bloo... | 18 Years - | DKMS gemeinnützige GmbH | |
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers | NCT00001873 | Chronic Lymphoc... Graft vs Host D... Hematologic Neo... Multiple Myelom... Myelodysplastic... | Isolex 300i plu... | 10 Years - 55 Years | National Institutes of Health Clinical Center (CC) | |
Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. | NCT01728389 | Leukemia Lymphoma | Intrabone trans... | 18 Years - 55 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis | NCT03520647 | Severe Aplastic... Hypo-Plastic My... Paroxysmal Noct... | Cyclophosphamid... Peripheral Bloo... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma | NCT01039025 | Myeloma | Topotecan Cyclophosphamid... Melphalan Peripheral Bloo... | - 70 Years | M.D. Anderson Cancer Center | |
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow | NCT00003838 | Myeloproliferat... Acute Myelogeno... Chronic Myeloge... Myelodysplastic... Acute Lymphobla... | T-cell replete ... Methotrexate Cyclosporine G-CSF | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia | NCT00001623 | Graft vs Host D... Hematologic Neo... Leukemia Multiple Myelom... Myelodysplastic... | Allogeneic Bone... | 10 Years - 55 Years | National Institutes of Health Clinical Center (CC) | |
Haploidentical Donor vs mMUD in Hematological Malignancies | NCT03275636 | AML ALL MDS | Peripheral bloo... | 18 Years - | DKMS gemeinnützige GmbH | |
Stem Cell Transplantation for Metastatic Solid Tumors | NCT00001880 | Neoplasm Metast... | methotrexate Cyclosporin | 10 Years - 80 Years | National Institutes of Health Clinical Center (CC) |